A phase II trial of paclitaxel in refractory germ cell tumors
- 1 April 1998
- Vol. 82 (7) , 1381-1386
- https://doi.org/10.1002/(sici)1097-0142(19980401)82:7<1381::aid-cncr23>3.0.co;2-1
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Phase II study of paclitaxel in patients with relapsed or cisplatin-refractory testicular cancerAnnals of Oncology, 1996
- Computerized Quantitation of Synergism and Antagonism of Taxol, Topotecan, and Cisplatin Against Human Teratocarcinoma Cell Growth: a Rational Approach to Clinical Protocol DesignJNCI Journal of the National Cancer Institute, 1994
- Phase II Trial of High-Dose Carboplatin and Etoposide With Autologous Bone Marrow Transplantation in First-Line Therapy for Patients With Poor-Risk Germ Cell TumorsJNCI Journal of the National Cancer Institute, 1993
- Surgical salvage of chemorefractory germ cell tumors.Journal of Clinical Oncology, 1993
- Randomized study of cisplatin dose intensity in poor-risk germ cell tumors: a Southeastern Cancer Study Group and Southwest Oncology Group protocol.Journal of Clinical Oncology, 1991
- The role of ifosfamide plus cisplatin-based chemotherapy as salvage therapy for patients with refractory germ cell tumorsCancer, 1990
- Evaluation of optimal duration of chemotherapy in favorable-prognosis disseminated germ cell tumors: a Southeastern Cancer Study Group protocol.Journal of Clinical Oncology, 1989
- Successful treatment of resistant germinal neoplasms with VP-16 and cisplatin: results of a Southeastern Cancer Study Group trial.Journal of Clinical Oncology, 1985
- Taxol stabilizes microtubules in mouse fibroblast cells.Proceedings of the National Academy of Sciences, 1980
- Promotion of microtubule assembly in vitro by taxolNature, 1979